share_log

12 Health Care Stocks Moving In Thursday's After-Market Session

Benzinga ·  Mar 21 17:33

Gainers

  • Biolase (NASDAQ:BIOL) stock rose 20.0% to $0.18 during Thursday's after-market session. The market value of their outstanding shares is at $3.4 million. As per the press release, Q4 earnings came out today.
  • Terns Pharma (NASDAQ:TERN) shares rose 10.14% to $7.21. The company's market cap stands at $466.4 million.
  • Aptevo Therapeutics (NASDAQ:APVO) stock increased by 9.37% to $4.9. The market value of their outstanding shares is at $2.6 million.
  • Nexalin Technology (NASDAQ:NXL) shares increased by 7.62% to $0.48. The company's market cap stands at $3.4 million.
  • Evolus (NASDAQ:EOLS) stock moved upwards by 7.61% to $14.84. The company's market cap stands at $912.6 million.
  • Phio Pharma (NASDAQ:PHIO) stock moved upwards by 7.52% to $0.9. The market value of their outstanding shares is at $4.1 million.

Losers

  • Cutera (NASDAQ:CUTR) stock decreased by 11.7% to $2.03 during Thursday's after-market session. The company's market cap stands at $40.5 million. As per the press release, Q4 earnings came out today.
  • Hyperfine (NASDAQ:HYPR) stock declined by 7.97% to $1.04. The company's market cap stands at $74.4 million. As per the press release, Q4 earnings came out today.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock declined by 7.66% to $1.81. The market value of their outstanding shares is at $1.0 million.
  • Vicarious Surgical (NYSE:RBOT) stock decreased by 5.24% to $0.36. The company's market cap stands at $63.2 million.
  • Meihua Intl Medical Techs (NASDAQ:MHUA) stock fell 5.14% to $0.79. The company's market cap stands at $19.8 million.
  • Assure Hldgs (NASDAQ:IONM) stock fell 4.81% to $0.5. The market value of their outstanding shares is at $4.0 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment